Chris Lamb is a Consultant Gastroenterologist at the Newcastle upon Tyne Hospitals and Professor of Gastroenterology at Newcastle University. He has a specialist interest in IBD and his research focuses on the intestinal immune system, how this maintains health or can drive inflammation, and how our immune system interacts with, and is shaped by gut microbiota (bacteria, viruses, and fungi). A previous Wellcome Trust Clinical Fellow in Translational Medicine and Therapeutics and an NIHR Clinical Lecturer, Chris is now the Chief Investigator for the national IBD-RESPONSE and CD-metaRESPONSE studies funded by the Medical Research Council and Helmsley Charitable Trust which aim to use machine learning to develop a predict model of response to immune modifying therapy in IBD based on gut microbiome and metabonomic data. Chris is the lead author of the 2019 British Society of Gastroenterology guidelines for the management of IBD and was the Secretary of the IBD section of the British Society of Gastroenterology from 2021 to 2024.

Gareth Parkes trained at Cambridge University and Bart’s & the London and was awarded a PhD at King’s College London. He now works as a Consultant in Gastroenterology at the Royal London Hospital, Barts Health NHS Trust. His interests include out-patient transformation, clinical trials in IBD, the role of the microbiota and probiotics and the use of technology in IBD OPD. Gareth is the Secretary of the British Society of Gastroenterology IBD Committee, has a range of publications in the field of IBD, GI microbiota and IBS. He is the co-founder and Medical Director of Ampersand Health which has developed the award-winning mobile application MyIBD Care utilising digital technology and behavioural science to improve the lives of patients with IBD as well as developing platforms in other Immune Mediated Inflammatory Diseases.

Tim Raine leads the IBD clinical service and the IBD trials unit at Cambridge University Hospitals, UK. Tim is a past chair of the ECCO (European Crohn’s and Colitis Organisation) guidelines committee and is a lead author on several ECCO guidelines. He currently serves on the scientific committee for both ECCO and UEG. Tim is chief investigator of several clinical trials, including first-in-man as well as later phase clinical trials. He has a particular interest in the design and delivery of clinical trials in acute severe ulcerative colitis as well as efficient early-phase trials incorporating novel scientific endpoints to inform decision making. He has served on the British Society of Gastroenterology IBD clinical research group and led and facilitated delivery of investigator-initiated clinical trials in the UK. He is an honorary faculty member of the Wellcome Trust Sanger Centre, UK. His research, funded by the Wellcome Trust, CCFA, Crohn’s and Colitis UK, OpenTargets and the National Institute for Health Research, focuses on the regulation of the gastrointestinal immune system.

Nuru Noor is a Clinical Lecturer in Gastroenterology at the University of Cambridge and a Postdoctoral Researcher in Clinical Trial Methodology at the Medical Research Council Clinical Trials Unit. He has clinical and academic interests in IBD and clinical trials – with a focus on innovative approaches to trial design, conduct, and analysis.

Jonny Blackwell is a Consultant Luminal Gastroenterologist at the Edinburgh IBD Unit. He completed his MD at St George’s University of London, where his research harnessed Big Data to explore the epidemiology, natural history, and psychological aspects of IBD. He is a member of the BSG IBD Guideline Development Group and focussed on questions of de-escalating therapies and therapeutic drug monitoring in IBD. He is an honorary senior clinical lecturer at the University of Edinburgh and has a passion for medical education, currently establishing an IBD educational programme at the Western General Hospital, Edinburgh. He is an associate editor for Frontline Gastroenterology in the IBD section. He vaguely remembers the liver.

Misha Kabir is a Consultant Gastroenterologist with a subspecialist interest in IBD at University College London Hospital. Her research interests include the prevention and management of colitis-associated neoplasia and optimising shared decision-making with patients. Her PhD based at St Mark’s Hospital led to the development of international expert consensus statements and an externally validated cancer risk calculator. She is a member of the BSG guideline developments groups updating

Vikki Garrick has dedicated her career to the NHS for the last 36 years – 24 of which have been in senior specialist roles and the last 20 of which were in the field of IBD. She designed and implemented the first paediatric IBD nurse service in Glasgow in 2006, and was operational lead for that service until 2021, when she took up a more strategic role as the first paediatric IBD Nurse Consultant in Scotland, also becoming the first paediatric RCN Advanced Clinical Practitioner in IBD in Scotland.
In 2024, she decided to leave the NHS, taking on the exciting new role of Director of Patient Services for The Catherine McEwan Foundation, a charity which supports and empowers young people and adults living with IBD to live their best life despite their condition.
Vikki has always been a keen proponent of MDT working and person-centred approaches to patient management, so she is delighted to be able to transfer this skillset to the third sector. She remains a passionate advocate for people living with IBD – particularly young people – and is delighted to be able to continue this conversation with her NHS partners.

Aditi Kumar is a newly qualified Consultant Gastroenterologist with a sub-specialist interest in IBD at the Royal Wolverhampton NHS Trust. She qualified from the University of Birmingham Medical School in 2007 after having obtained her Bsc (Hons) in Biomedical Sciences at the University of Ottawa, Canada. During her registrar training, Dr Kumar obtained her PhD with her work focusing on bile acid diarrhoea in post-operative Crohn’s disease. Outside of her clinical duties, Dr Kumar is the deputy editor-in-chief at Frontline Gastroenterology.

Calum Moulton is a Consultant Liaison Psychiatrist at St Mark’s Hospital – the National Bowel Hospital – and an NIHR Advanced Fellow in the Department of Psychological Medicine, King’s College London. After completing his PhD in type 2 diabetes and depression, he developed his subspecialism in gastropsychiatry. He runs a specialist clinic for patients with IBD and comorbid fatigue, depression and pain. As well antidepressant treatments, he has an interest in novel psychotropic approaches for severe fatigue in IBD. He is the Chief Investigator on the largest clinical trial to date of an antidepressant in patients with IBD, as well as co-investigator on a psychological therapy trial for pain in IBD.

Peter Rimmer is a Consultant Gastroenterologist and Honorary Senior Research Fellow at University Hospitals Birmingham having completed academic training in September 2024.
During his PhD years he developed and continues to deliver an integrated clinical and research pathway for IBD diagnosis. His key research interests included the pre-treatment microbiome and mucosal immune landscape in IBD. He also leads the delivery of IBD care in one of the largest dedicated PSC-IBD clinics in Europe.
He is a part of the clinical team at the Microbiome Treatment Centre in the University of Birmingham and is involved delivery of faecal microbial transplantation in both a clinical and research setting.

Tom Conley is a Gastroenterology Specialty Trainee at Liverpool University Hospitals NHS Foundation Trust, with his Certificate of Completion of Training (CCT) expected in the coming academic year. His clinical interests include Inflammatory Bowel Disease (IBD), Intestinal Failure (IF), and Neurogastroenterology. Tom has undertaken advanced fellowships in IBD, IF, and clinical nutrition, and served on the BSG Small Bowel and Nutrition committee.
He is actively involved in research, currently coordinating a clinical trial on the use of low-dose oral iron in patients with IBD and contributing to several projects examining the relationship between the gut microenvironment and Irritable Bowel Syndrome. Recently, he returned to training after taking time out of his programme to conduct postgraduate research at the University of Liverpool with Professor Probert, where he focused on the role of volatile organic compounds as biomarkers in gastroenterology.

Karishma Sethi-Arora is a Post-CCT Fellow in Advanced IBD at the Northern Care Alliance. She completed an MBBS, with BSc in Gastroenterology, from Imperial College London. She undertook speciality training in Gastroenterology in London’s North-East Thames deanery before moving to the North-West.

Clinically, her interests lie in the management of Inflammatory Bowel Disorders, with particular interests in women’s health and IBD management in older persons. She is currently undertaking a sub-speciality fellowship in Advanced Inflammatory Bowel disease, in which she is sub-investigator on a number of commercial studies and investigator-led, portfolio studies in IBD.

She has a keen interest in clinical leadership and organisational culture and has a post-graduate certificate with distinction in Leadership in Healthcare.

She is a passionate clinical educator and, in 2022, won the BSG’s Alistair McIntyre Prize for Improving Training in Gastroenterology, for her work in developing an e-learning package for the national dissemination of human factors training in endoscopy.

She has recently been appointed as a Consultant in Luminal Gastroenterology and IBD at Manchester Foundation Trust.